Does Antibiotics Use During Surgery Help to Decrease Wound Infection and Increase Success After Ear Surgery in Children
Comparison of Postoperative Infection and Graft Uptake Rate Using Single Dose of Intravenous Co-amoxiclav Versus no Antibiotic in Children Undergoing Myringoplasty
1 other identifier
interventional
60
0 countries
N/A
Brief Summary
This study assess whether there is any role of antibiotics to decrease wound infection and increase the success of surgery
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_4
Started Jan 2014
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 10, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 6, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2015
CompletedFirst Submitted
Initial submission to the registry
September 29, 2018
CompletedFirst Posted
Study publicly available on registry
October 9, 2018
CompletedOctober 10, 2018
October 1, 2018
1.4 years
September 29, 2018
October 8, 2018
Conditions
Outcome Measures
Primary Outcomes (1)
: Number of Participants with postoperative wound infection
Number of participants who have had at least one episode of infection in the postoperative period. postoperative infection : Infection occurring within 4 weeks of postoperative periods Postoperative infection : Presence of any of the following findings on clinical examination 1. Wound gaping 2. Purulent discharge from incision site 3. Purulent discharge from external auditory canal Measurement tool used to assess the measure * Clinical examination of patient by examiner * Wound assessment : Examination of pinna , incision site and graft donor site * Any signs of infections if present will be noted in performa.
At Visit 1, [Post-op Day 1 ], at Visit 2 [Post-op Day 3] ,at Visit 3 [Day 8 to Day 14] ], at Visit 4 [ Day 28 to day 30]
Secondary Outcomes (1)
Number of Participants with successful graft uptake
At Visit 4 [ Day 28 to day 30], at Visit 5 [ day 80 to day 90]
Study Arms (2)
Antibiotics group
EXPERIMENTALPatients in this group will receive single dose of intravenous co-amoxiclav (Dose: 25 mg/kg body weight) which will be injected 30 minutes prior to the incision during surgery.
No antibiotics group
NO INTERVENTIONPatients belonging to this group will not receive any systemic antibiotic during intraoperative or post-operative period.
Interventions
Patients in this group will receive single dose of intravenous co-amoxiclav (Dose: 25 mg/kg body weight) which was injected 30 minutes prior to the incision during surgery.
Eligibility Criteria
You may qualify if:
- Age : patients between 6 to 15 years of age
- Gender : both male and female patients
- Disease: Chronic otitis media mucosal inactive (dry for at least 4 weeks)
You may not qualify if:
- Actively discharging ear pre-operatively
- Revision myringoplasty
- Allergic to co-amoxiclav
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Publications (1)
Khanal P, Guragain RP, Bhusal CL. Comparison of postoperative infection and graft uptake rate using single dose of intravenous co-amoxiclav versus no antibiotic in children undergoing myringoplasty: A randomized controlled trial. Int J Pediatr Otorhinolaryngol. 2020 Apr;131:109893. doi: 10.1016/j.ijporl.2020.109893. Epub 2020 Jan 18.
PMID: 31981921DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Prakash Khanal, MS,ENT
Ganesh Man Singh Memorial Academy (GMSMA) of ENT-Head and Neck Studies, TU Teaching Hospital, Institute of Medicine (IOM)
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- ENT- Head and Neck Surgeon
Study Record Dates
First Submitted
September 29, 2018
First Posted
October 9, 2018
Study Start
January 10, 2014
Primary Completion
June 6, 2015
Study Completion
September 1, 2015
Last Updated
October 10, 2018
Record last verified: 2018-10